✦ LIBER ✦

Therapy conversion to biphasic insulin aspart 30 improves long-term outcomes and reduces the costs of type 2 diabetes in Saudi Arabia

✍ Scribed by Ali, Mohammed; White, Jeremy; Lee, Chen-Hui; Palmer, James L; Smith-Palmer, Jayne; Fakhoury, Walid; Valentine, William J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short And Long-Term Cost-Effectiveness O

✍ Home, P.D.; Soewondo, P.; Shafie, A.A.; AlRaddady, K.; Baadbad, R.; Hammerby, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Short And Long-Term Cost-Effectiveness O

✍ Home, P.D.; Soewondo, P.; Hussein, Z.; Shafie, A.A.; AlRaddady, K.; Baadbad, R.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB4 LONG-TERM OUTCOMES OF SWITCHING PAT

✍ R Ligthelm; TE Christensen; TL Thomsen; W Yang 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

DB1 EVALUATING THE COST-EFFECTIVENESS OF

✍ Chang, J; Sun, F; Li, H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Short And Long-Term Cost-Effectiveness O

✍ Home, P.D.; Soewondo, P.; Hussein, Z.; Shafie, A.A.; AlRaddady, K.; Baadbad, R.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB20 BIPHASIC INSULIN ASPART 30 VERSUS

✍ AJ Palmer; M Lammert; WJ Valentine; JA Ray; AS Brandt; S Roze 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB